Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Media Farmasi Journal of Biomedical Sciences and Health
aswad, hijral
Unknown Affiliation
Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Sinergitas Efek Kombinasi Ekstrak Daun SirsaK (Annona muricata Linn) Dengan Doksorubisin Pada Sel Kanker Payudara MCF-7 Lukman; Aswad, Hijral; Lestari, Desy Ayu; Paluseri, Andi
Media Farmasi Vol 20 No 2 (2024): Media Farmasi Edisi Oktober 2024
Publisher : Jurusan Farmasi Poltekkes kemenkes Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32382/mf.v20i2.832

Abstract

Doxorubicin is the first line of cancer treatment but has very serious side effects such as hair loss, kidney damage and liver function abnormalities. One strategy to reduce these side effects is to combine doxorubicin with medicinal plants with anti-cancer properties such as soursop leaves (Annona muricata Linn). The aim of this research is to determine the synergistic effect of the combination of soursop leaf extract with doxorubicin to inhibit the growth of MCF-5 breast cancer cells. Soursop leaves were extracted with 96% ethanol while the anti-cancer test used the MTT method. The results of the study showed that soursop leaf extract had anti-cancer properties with IC25 and IC50 respectively being 29.36 ± 1.16 and 58.75 ± 2.35 µg/mL while doxorubicin was 1.34 ± 0.04 and 2. 76 ± 0.03 µg/mL. The combination of soursop leaf extract and doxorubicin showed a value of 0.8-1.0 (moderate synergistic). In conclusion, the combination of soursop leaf extract and doxorubicin shows a synergistic effect.
Cytotoxic Activity of Chromolaena odorata Leaf Extract on WiDr Colon Cancer Cells Anam, Hairul; Aswad, Hijral; Irma, Ade; Wahdaniar
Journal of Biomedical Sciences and Health Vol. 3 No. 1 (2026)
Publisher : Universitas Karya Husada Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34310/jbsh.v3.i1.300

Abstract

Background: Colorectal cancer (CRC) remains the third most commonly diagnosed cancer and the second leading cause of cancer-related mortality worldwide. In 2020, CRC accounted for approximately 1.9 million new cases and over 935,000 deaths globally. Conventional chemotherapy is frequently limited by systemic toxicity and drug resistance, necessitating the identification of novel plant-derived bioactive compounds. Chromolaena odorata (Asteraceae), a tropical medicinal plant, has demonstrated pharmacological properties including wound healing and anti-inflammatory activity; however, its antiproliferative potential against colorectal cancer cells remains insufficiently explored. Objective: This study aimed to evaluate the cytotoxic and antiproliferative effects of C. odorata n-hexane leaf extract on WiDr human colorectal adenocarcinoma cells using an in vitro MTT assay. Methods: Dried leaves of C. odorata were extracted via n-hexane maceration. WiDr cells were cultured in DMEM supplemented with 10% FBS and antibiotics. Cells were treated with graded extract concentrations (62.5–1000 μg/mL) for 24 hours in triplicate. Cell viability was assessed by the MTT assay and the half-maximal inhibitory concentration (IC₅₀) was determined via nonlinear regression analysis. Results: The extract exhibited concentration-dependent cytotoxicity against WiDr cells. The highest mean inhibition rate (94.3 ± 10.7%) was observed at 1000 μg/mL. The calculated IC₅₀ value was 149.09 ± 20.91 μg/mL, indicating moderate cytotoxic potency consistent with the National Cancer Institute (NCI) classification for biologically active crude extracts (IC₅₀ < 200 μg/mL). Conclusion: Chromolaena odorata n-hexane leaf extract demonstrates significant in vitro antiproliferative activity against WiDr colorectal cancer cells. The cytotoxic activity likely involves lipophilic bioactive compounds, including terpenoids. These findings support further bioassay-guided fractionation, mechanistic investigation, and in vivo validation as potential candidates for anticancer drug development.
Co-Authors Ade Irma Hairul Anam Lestari, Desy Ayu Lukman Muslimin paluseri, Andi Wahdaniar